C205404Level 4
Bevacizumab/Cyclophosphamide/Pembrolizumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of bevacizumab, oral cyclophosphamide and pembrolizumab that can be used for the treatment of ovarian, fallopian tube, and primary peritoneal cancers.
**Synonyms:** - Avastin/Cyclophosphamide/Keytruda - Bevacizumab-Cyclophosphamide-Pembrolizumab - Bevacizumab/Cyclophosphamide/Pembrolizumab - Bevacizumab/Oral Cyclophosphamide/Pembrolizumab - Oral Cyclophosphamide Plus Bevacizumab Plus Pembrolizumab - Oral Cyclophosphamide/Bevacizumab/Pembrolizumab
GET
/api/v1/systems/nci_thesaurus/nodes/C205404Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.